SKIN, RECOVERY & PERFORMANCE RESEARCH
Klow Blend
80 mg
Advanced Peptide Synergy for Real Results.
Klow Blend combines GHK-Cu, BPC-157, TB-500 and KPV in a powerful formulation designed to support healthier skin, faster recovery, reduced inflammation and overall wellness. This blend is intended for research purposes only.
A Healthier Tomorrow
Klow Blend
80 mg
$130.00 — or Original price was: $130.00.$117.00Current price is: $117.00. / month
Ships within 1-2 Business Days
Subscribe monthly and save 10%
- Ship to Canada,USA & Mexico
- Secure Checkout
- Add to wishlist
PREMIUM QUALITY:
Pharmaceutical-grade
INDEPENDENT TESTING:
Quality verification
BATCH TRANSPARENCY:
Product information
GLOBAL ACCESS:
Canada, USA & Mexico
SUPPORTING A HEALTHIER YOU
Research Today. Real Possibilities.
Klow Blend combines GHK-Cu, BPC-157, TB-500 and KPV to support key biological processes involved in skin health, tissue repair, recovery, reduced inflammation and overall cellular health. This blend is of interest for researchers exploring these pathways in preclinical models.
- Supports skin health and appearance (research)
- Supports faster recovery and tissue repair (research)
- Supports healthy inflammatory response (research)
- Supports cellular regeneration and longevity (research)
- Combines complementary peptides for enhanced research potential (research)
KEY AREAS OF HUMAN
KEY AREAS OF HUMAN
The Science
Evidence & Mechanism
Klow Blend combines GHK-Cu, BPC-157, TB-500 and KPV, which have been studied for their roles in copper signaling, tissue repair, cytoskeletal dynamics and inflammatory modulation. Each peptide contributes unique properties that may interact across these pathways in preclinical models. Controlled human clinical evidence for this exact combination has not been established.
Studied for its role in gene expression and extracellular matrix biology (preclinical research).
Studied for tissue repair-related signaling pathways (preclinical research).
Studied for its role in actin dynamics and cell migration (preclinical research).
Studied for its potential effects on NF-$\kappa$B and cytokine signaling pathways (preclinical research).
Product Information
| Product Name | Klow Blend |
| Components | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg |
| Total Strength | 80 mg (lyophilized) |
| Vial Size | 3 mL |
| Product Format | Lyophilized powder |
| Storage | Store refrigerated (2°C–8°C). Protect from light and moisture. |
| Intended Use | Research use only. Not approved for human use. |
Why Choose Nextgen
- Premium quality research products
- Independent laboratory testing
- Batch transparency
- Consistent quality standards
- Milligram App integration
- Dedicated customer support
FREQUENTLY ASKED QUESTIONS
Your Questions, Answered.
Find quick answers to common questions about this Product.
The listed KLOW formulation contains GHK-Cu, BPC-157 and TB-500, plus KPV. KPV has reduced inflammatory signalling in intestinal and immune cell experiments and in mouse colitis models. This provides a reason to investigate the added ingredient. It does not show that KLOW treats gut inflammation or performs better than GLOW in people.
GHK-Cu has increased collagen production in cultured cells, and BPC-157 has affected tendon-cell movement and stress survival. These findings concern the ingredients studied separately. They do not establish that combining them produces firmer skin, faster wound healing or superior recovery, and no clinical benefit can be inferred from the total amount in the vial.
TB-500 terminology can refer to materials different from full-length thymosin beta-4. This matters when interpreting repair studies. The exact component identity and blend composition must be matched to any cited experiment. Component research offers background, while benefits and adverse effects of the complete KLOW formulation require direct study.